Successful Twin Pregnancy Through ICSI in a 29-Year-Old with Four Failed IUIs, an Arcuate Uterus, and Recurrent Pregnancy Bleeding
A 29-year-old woman married for 10 years came to Dr. Mohit Saraogi at Saraogi Hospital & IRIS IVF Centre, Mumbai in April 2025 after four failed IUI cycles, along with multiple rounds of follicular monitoring and several natural cycles. Evaluation showed she was largely healthy with a slightly reduced egg count, while a hysteroscopy later revealed an arcuate uterus. As an experienced ivf doctor in mumbai, Dr. Mohit Saraogi managed the case with ICSI, a corrective metroplasty, and a fresh Day-5 transfer of two grade B blastocysts. The very first transfer succeeded, resulting in twins. Despite relentless bleeding episodes and a large intrauterine hematoma throughout the pregnancy, the patient was managed conservatively with tocolysis, immunosuppressants, and a cervical cerclage, and went on to deliver healthy term twins, one boy and one girl, each weighing 2 kg.
Patient Profile
| Age | 29 years |
| Gender | Female |
| Husband’s Age | 29 years |
| Married Since | 10 years |
| Presenting Complaint | Primary infertility of 10 years with four prior failed IUI cycles done elsewhere |
| Diagnosis | Primary infertility, slightly diminished ovarian reserve, arcuate uterus, poor egg and embryo quality (grade B blastocysts) |
| Date of Procedure | April 2025, with term twin delivery in early 2026 |
| Outcome | Healthy term twin live birth, one male and one female, 2 kg each. Mother and babies well |
The Problem
At 29, the patient had already spent a decade trying to conceive. Married for 10 years, she and her 29-year-old husband had been through four IUI cycles at other centres, in addition to multiple rounds of follicular monitoring and several natural cycles, none of which resulted in a pregnancy.
When the couple reached Saraogi Hospital in April 2025, a detailed ultrasound showed that the patient was largely healthy, with a slightly reduced egg count being the only notable finding. There was no major structural or hormonal abnormality on initial assessment. However, the long history of repeated treatment failure made it clear that simply continuing with the same line of treatment was unlikely to help.
A diagnostic hysteroscopy performed before the embryo transfer revealed an arcuate uterus, a congenital variation in the shape of the uterine cavity that can interfere with embryo implantation and increase the risk of pregnancy loss. Combined with a marginally low ovarian reserve and the eventual finding of poor egg and embryo quality, the clinical picture pointed to the need for an advanced, carefully individualised approach rather than another routine attempt.
Consultation And Treatment Plan
WHAT WAS ASSESSED DURING THE CONSULTATION
WHAT WAS ASSESSED DURING THE CONSULTATION
Dr. Mohit Saraogi conducted a detailed evaluation before planning treatment:
- Complete history of four failed IUI cycles, follicular monitoring and natural cycles reviewed
- Pelvic ultrasound showed a largely normal pelvis with a slightly reduced egg count (diminished ovarian reserve)
- Both partners’ fertility factors assessed, along with the couple’s goals and emotional readiness
- Uterine cavity evaluated by diagnostic hysteroscopy, which revealed an arcuate uterus
- Overall medical fitness for an IVF cycle confirmed
WHY THIS TREATMENT APPROACH WAS CHOSEN
- ICSI was recommended over a repeat IUI because four IUI cycles had already failed, and injecting a single sperm directly into each egg maximises the chance of fertilisation
- Pre-transfer hysteroscopy with metroplasty was planned to correct the arcuate uterus and optimise the cavity before any embryo was placed
- A Day-5 blastocyst transfer was chosen so that the most viable embryos could be selected, which was especially important given the slow embryo growth observed
- Transparent counselling was prioritised: as only two grade B blastocysts were available, the couple was clearly informed that success rates would be slightly lower before they chose to proceed
- Close antenatal monitoring was anticipated, given the corrected uterus and the higher-risk nature of a twin pregnancy
Clinical Illustration
An arcuate uterus is a mild congenital anomaly in which the top (fundus) of the uterine cavity is slightly indented inward rather than smoothly curved. While it is one of the milder uterine variations, it can still affect where and how an embryo implants and, in some cases, contribute to bleeding and pregnancy loss. In this patient, the arcuate cavity was identified on hysteroscopy and corrected with a minor metroplasty before embryo transfer. The illustration below compares a typical uterine cavity with the arcuate cavity seen in this case.
Procedure Details
- Ovarian stimulation started with injectable medication and tracked through follicular monitoring
- Egg retrieval performed; a reasonable number of eggs collected, though egg quality was suboptimal
- Eggs fertilised with the husband’s sperm using ICSI
- Embryos cultured to day 5; growth was slow, yielding two grade B blastocysts
- Diagnostic hysteroscopy performed, revealing an arcuate uterus; a slight metroplasty was done to correct the cavity
- Fresh Day-5 embryo transfer of the two grade B blastocysts performed
- Pregnancy confirmed on the first transfer; twin gestation identified on early scan
- First bleeding episode at 5 to 6 weeks; patient admitted, bleeding controlled with tocolysis and immunosuppressants, and the pregnancy maintained
- Three days later, a heavy bleeding episode with large clots; ultrasound remained normal with both fetal heartbeats present
- A large intrauterine hematoma measuring 5 by 5 cm developed from the repeated bleeding
- A third bleeding episode within a span of 10 days required readmission; the heartbeat remained strong
- At 9 weeks, clots of 4 by 4 cm and 2 by 2 cm were noted behind both babies; bleeding continued but fetal heart rates stayed normal
- Bleeding episodes persisted through 12 weeks, likely related to a weak uterine lining and the lower grade of the embryos
- At 15 weeks, further bleeding occurred and the hematoma increased to around 6 cm; managed conservatively and successfully
- A cervical cerclage (stitch) was placed, along with continued immunosuppressant therapy, to support the pregnancy
- After the cerclage, the patient had only one further bleeding episode, and by 18 weeks the bleeding stopped completely
- The patient delivered healthy twin babies at term, one boy and one girl, each weighing approximately 2 kg
Procedure Facts
| Procedure | Hysteroscopy + Metroplasty, ICSI (IVF), Day-5 Blastocyst Transfer, Cervical Cerclage |
| Primary Diagnosis | Primary infertility with arcuate uterus and four prior failed IUIs |
| Uterine Correction | Slight metroplasty for arcuate uterus |
| Embryos Generated | Two grade B Day-5 blastocysts via ICSI |
| Gestation Type | Twin pregnancy from first transfer |
| Anaesthesia | Short general / sedation for egg retrieval and hysteroscopy |
| Gestation at Delivery | Term |
| Baby Weights | Twin 1: 2 kg, Twin 2: 2 kg (one male, one female) |
| Maternal Complications | Recurrent antenatal bleeding with a 5 to 6 cm intrauterine hematoma, managed conservatively |
Outcomes At A Glance
| Conception | Achieved on the first embryo transfer attempt, resulting in twins |
| Pregnancy Continuation | Successfully carried to term despite recurrent bleeding and a large hematoma |
| Baby Outcome | Healthy term twins, 2 kg each, one boy and one girl |
| Maternal Outcome | Stable and well after delivery |
| Patient Satisfaction | Very high. Long-awaited parenthood achieved after 10 years of infertility |
| Complications | Repeated bleeding episodes and intrauterine hematoma, all managed successfully |
Patient Feedback
Feedback recorded after the twin delivery at Saraogi Hospital, Mumbai.
| Google Review ★ ★ ★ ★ ★ 5.0 “We had spent ten years trying, with four failed IUIs, and we had almost lost hope. Dr. Mohit Saraogi explained everything to us honestly and never gave up, even when I bled again and again through the pregnancy. Today we have two healthy babies, a boy and a girl. We are still in disbelief.” Profile: Female | 29 years | Married 10 years | Mumbai Procedure: ICSI, Hysteroscopy with Metroplasty, Cervical Cerclage | Saraogi Hospital, Mumbai | 2025 Clinician: Dr. Mohit R. Saraogi | Saraogi Hospital & IRIS IVF Centre Note: Due to privacy regulations, we cannot display the patient’s name. This feedback has been shared with the patient’s written consent. |
Post-Procedure Care And Recovery
- Luteal-phase hormonal support continued after the embryo transfer
- Immunosuppressant therapy maintained to support implantation and reduce the risk of pregnancy loss
- Strict rest advised after the cervical cerclage placement
- Regular monitoring for bleeding episodes and abdominal pain throughout the pregnancy
- Tocolytic therapy administered during bleeding episodes to help maintain the pregnancy
- Serial ultrasound monitoring of both fetal heartbeats and the intrauterine hematoma
- Frequent antenatal visits, with closer monitoring during high-risk phases
- Mother counselled and supported emotionally throughout the high-risk pregnancy
- Both babies delivered healthy at term, with no major neonatal intervention required
Recovery Timeline
| Pre-Transfer Phase | ICSI cycle completed; hysteroscopy with metroplasty performed to correct the arcuate uterus |
| Week 5 to 6 | First bleeding episode. Admitted and controlled with tocolysis and immunosuppressants. Pregnancy maintained |
| Around Week 9 | Clots of 4 by 4 cm and 2 by 2 cm behind both babies. Fetal heartbeats remained normal |
| Week 12 | Bleeding episodes continued; managed conservatively with close monitoring |
| Week 15 | Repeat bleeding; hematoma increased to around 6 cm. Successfully managed; cervical cerclage placed |
| After Week 18 | Bleeding stopped completely. Pregnancy progressed smoothly |
| Term | Delivery of healthy twins, one boy and one girl, 2 kg each. Mother and babies well |
DISCLAIMER: This case study is for informational purposes only and does not constitute medical advice. Individual results may vary. Consult a qualified fertility specialist before undergoing any procedure. Patient feedback published with written consent. Patient identity withheld per confidentiality guidelines.
